MTD
Price
$1238.33
Change
-$18.70 (-1.49%)
Updated
Sep 24, 12:12 PM (EDT)
Capitalization
25.89B
43 days until earnings call
NVST
Price
$20.78
Change
-$0.06 (-0.29%)
Updated
Sep 24, 12:18 PM (EDT)
Capitalization
3.46B
35 days until earnings call
Interact to see
Advertisement

MTD vs NVST

Header iconMTD vs NVST Comparison
Open Charts MTD vs NVSTBanner chart's image
Mettler-Toledo International
Price$1238.33
Change-$18.70 (-1.49%)
Volume$400
Capitalization25.89B
Envista Holdings
Price$20.78
Change-$0.06 (-0.29%)
Volume$500
Capitalization3.46B
MTD vs NVST Comparison Chart in %
Loading...
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MTD vs. NVST commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MTD is a StrongBuy and NVST is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (MTD: $1257.03 vs. NVST: $20.84)
Brand notoriety: MTD and NVST are both not notable
MTD represents the Medical Specialties, while NVST is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: MTD: 98% vs. NVST: 96%
Market capitalization -- MTD: $25.89B vs. NVST: $3.46B
MTD [@Medical Specialties] is valued at $25.89B. NVST’s [@Pharmaceuticals: Other] market capitalization is $3.46B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $160.51B to $0. The average market capitalization across the [@Medical Specialties] industry is $10.62B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MTD’s FA Score shows that 1 FA rating(s) are green whileNVST’s FA Score has 0 green FA rating(s).

  • MTD’s FA Score: 1 green, 4 red.
  • NVST’s FA Score: 0 green, 5 red.
According to our system of comparison, both MTD and NVST are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MTD’s TA Score shows that 4 TA indicator(s) are bullish while NVST’s TA Score has 4 bullish TA indicator(s).

  • MTD’s TA Score: 4 bullish, 5 bearish.
  • NVST’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, NVST is a better buy in the short-term than MTD.

Price Growth

MTD (@Medical Specialties) experienced а -1.49% price change this week, while NVST (@Pharmaceuticals: Other) price change was -1.23% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.95%. For the same industry, the average monthly price growth was +3.73%, and the average quarterly price growth was +26.50%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.28%. For the same industry, the average monthly price growth was -1.82%, and the average quarterly price growth was +9.28%.

Reported Earning Dates

MTD is expected to report earnings on Nov 06, 2025.

NVST is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Medical Specialties (+0.95% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-0.28% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MTD($25.9B) has a higher market cap than NVST($3.46B). NVST has higher P/E ratio than MTD: NVST (65.13) vs MTD (31.87). NVST YTD gains are higher at: 8.035 vs. MTD (2.725). MTD has higher annual earnings (EBITDA): 1.22B vs. NVST (303M). NVST has more cash in the bank: 1.11B vs. MTD (61.8M). NVST has less debt than MTD: NVST (1.6B) vs MTD (2.18B). MTD has higher revenues than NVST: MTD (3.87B) vs NVST (2.55B).
MTDNVSTMTD / NVST
Capitalization25.9B3.46B748%
EBITDA1.22B303M401%
Gain YTD2.7258.03534%
P/E Ratio31.8765.1349%
Revenue3.87B2.55B151%
Total Cash61.8M1.11B6%
Total Debt2.18B1.6B137%
FUNDAMENTALS RATINGS
MTD vs NVST: Fundamental Ratings
MTD
NVST
OUTLOOK RATING
1..100
5865
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
73
Overvalued
PROFIT vs RISK RATING
1..100
71100
SMR RATING
1..100
391
PRICE GROWTH RATING
1..100
5952
P/E GROWTH RATING
1..100
6946
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVST's Valuation (73) in the null industry is in the same range as MTD (100) in the Medical Specialties industry. This means that NVST’s stock grew similarly to MTD’s over the last 12 months.

MTD's Profit vs Risk Rating (71) in the Medical Specialties industry is in the same range as NVST (100) in the null industry. This means that MTD’s stock grew similarly to NVST’s over the last 12 months.

MTD's SMR Rating (3) in the Medical Specialties industry is significantly better than the same rating for NVST (91) in the null industry. This means that MTD’s stock grew significantly faster than NVST’s over the last 12 months.

NVST's Price Growth Rating (52) in the null industry is in the same range as MTD (59) in the Medical Specialties industry. This means that NVST’s stock grew similarly to MTD’s over the last 12 months.

NVST's P/E Growth Rating (46) in the null industry is in the same range as MTD (69) in the Medical Specialties industry. This means that NVST’s stock grew similarly to MTD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MTDNVST
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
54%
Bullish Trend 1 day ago
73%
Momentum
ODDS (%)
Bearish Trend 1 day ago
57%
Bullish Trend 1 day ago
63%
MACD
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
63%
Bearish Trend 1 day ago
70%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
65%
Bullish Trend 1 day ago
70%
Advances
ODDS (%)
Bullish Trend 9 days ago
62%
Bullish Trend 20 days ago
66%
Declines
ODDS (%)
Bearish Trend 1 day ago
62%
Bearish Trend 1 day ago
69%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
68%
Bearish Trend 1 day ago
61%
Aroon
ODDS (%)
Bearish Trend 1 day ago
64%
Bullish Trend 1 day ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FELTX101.55N/A
N/A
Fidelity Advisor Semiconductors M
TSVAX18.64-0.01
-0.05%
PGIM Quant Solutions Small-Cap Val A
TEQAX30.54-0.07
-0.23%
Touchstone Non-US Equity A
EVDIX22.12-0.06
-0.27%
Camelot Event Driven Institutional
MFEJX215.75-2.78
-1.27%
MFS Growth R4

MTD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTD has been closely correlated with A. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTD jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTD
1D Price
Change %
MTD100%
-0.08%
A - MTD
83%
Closely correlated
-0.31%
RVTY - MTD
79%
Closely correlated
-0.65%
TMO - MTD
77%
Closely correlated
-1.10%
WAT - MTD
75%
Closely correlated
-1.08%
BRKR - MTD
71%
Closely correlated
+1.77%
More

NVST and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVST has been loosely correlated with A. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if NVST jumps, then A could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVST
1D Price
Change %
NVST100%
-0.24%
A - NVST
57%
Loosely correlated
-0.31%
MTD - NVST
56%
Loosely correlated
-0.08%
SOLV - NVST
55%
Loosely correlated
-0.50%
XRAY - NVST
55%
Loosely correlated
-2.11%
BIO - NVST
53%
Loosely correlated
-0.46%
More